The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome

European Journal of Applied Physiology

Volumn 98, Issue 5, 2006, Pages 472-481

  Ring Dimitriou, Susanne ^a   Paulweber, Bernhard ^a   Duvillard, Serge P ^b   Stadlmann, Monika ^a   LeMura, Linda M ^c   Lang, Josef ^a   Müller, Erich ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b TEXAS A AND M UNIVERSITY COMMERCE   (United States)

^c LE MOYNE COLLEGE   (United States)

Author keywords

Adiponectin; Aerobic fitness; Exercise; Metabolic syndrome

Indexed keywords

ADIPONECTIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AEROBIC EXERCISE; AGED; ANALYSIS OF VARIANCE; ARTICLE; BICYCLE ERGOMETRY; BODY COMPOSITION; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE PREDISPOSITION; EXERCISE INTENSITY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KINESIOTHERAPY; MALE; METABOLIC SYNDROME X; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE;

ADIPONECTIN; ADULT; AGED; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; PHYSICAL FITNESS; RISK FACTORS;

EID: 33845294091     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-006-0291-9     Document Type: Article

References (37)

1. Borghouts LB, Backx K, Mensink MF, Keizer HA (1999) Effect of training intensity on insulin sensitivity as evaluated by insulin tolerance test. Eur J Appl Physiol 80:461-466
2. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier J-F (2003) Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 149(5): 421-424
3. Buemann B, Sorensen TIA, Pedersen O, Black E, Holst C, Toubro s, Echwald S, Holst JJ, Rasmussen C, Astup A (2005) Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin. Int J Obesity 29:624-631
4. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob JJ, Black AE, Maas D, Tahashi M, Kihara s, tanaka s, Matsuzawa Y, Blangero J, Cohen D, Kissebah A (2001) The genetic basis of plasma variation in adiponectin, a global endophenotypoe for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86(9):4321-4325
5. Eriksson J, Lindström J, Valle T, Aunola S, Hámálainen H, Ilanne-Parikka P, Keinánen-Kiukaanniemi S., Laakso M, Lauhkonen M., Lehto P, Lehtonen A, Louheranta A, Mannelin M., Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J (1999) Prevention of type II diabetes in subjects with impaired glucose tolerance: The diabetes prevention study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793-801
6. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289(14):1799-1804
7. Ferguson MA, White LJ, McCoy S, Kim H-W, Petty T, Wilsey J (2004) Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 91:324-329
8. Haque WA, Shimomura I, Matsuzawa Y, Garg A (2002) Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87(5):2395-2398
9. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, Okazaki Y, Ishii T, Oguma Y, Takei I, Saruta T (2002). Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51(3):341-347
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Murguchi M, Ohmoto Y, Nakmura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
11. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, Macdonald KG, Dohm GL (2002) Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283:E861-E865
12. IDF consensus worldwide definition of the metabolic syndrome (2005). http://www.idf.org. Cited 14 April 2005
13. Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A (2003) Effect of exercise on total and intra-abdominal body fat in postmenopausal women. JAMA 289(3):323-330
14. Jurimae J, Purge P, Jurimae T (2005) Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 93(4):502-505
15. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y (2001) Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24(2):362-365
16. Kraemer RR, Aboudehen KS, Carruth AK, Durand RJ, Acevedo EO, Hebert EP, Johnson LG, Daniel CV (2003) Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc 35(8):1320-1325
17. Kriketos AD, Gan SK, Poyneten AM, Furler SM, Chisholm DJ, Campbell LV (2004) Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27(2):629-630
18. Lean MEJ, Han TS, Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. Br Med J 311:158-161
19. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD (2005) Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metab Clin Exp 54:533-541
20. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzros CS (2003) Effect of lifestyle modification on adipokine levels in obese subject with insulin resistance. Obes Res 11:1048-1054
21. NCEP (National cholesterol Education Program) ATP III (Adult Treatment Panel III) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486-2497
22. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291(14):1730-1737
23. Punyadeera C, Zorenc AHG, Koopman R, McAinch AJ, Smit E, Manders R, Keizer HA, Cameron-Smith D, van Loon LJC (2005) Clinical Study: The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 153(3):427-436
24. Qi L, Rimm E, Liu S, Rifai N, Hu FB (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28(5):1022-1028
25. Ring S, Paulweber B, Weiss M, Mueller E (2003) Long-term effects of an exercise intervention on physical fitness and apolipoproteins in people with metabolic syndrome. In: Jeschke D and Lorenz R (eds) Sportmedizinische trainingssteuerung. Sport-Právention-Therapie Köln: Sport und Buch Strauβ 339-348
26. Ross R, Freeman J, Janssen I (2000) Exercise alone is an effective strategy for reducing obesity and related comorbidities. Exerc Sport Sci Rev 28(4):165-170
27. Ryan AS, Nicklas BJ, Berman DM, Elahi D (2003a) Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postemopausal women. Int J Obes 27(9):1066-1071
28. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerlich RL, Meneilly GS, Egan JM, Elahi D (2003b) Plasma adiponectin an leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26(8):2383-2388
29. Tsukinoki R, Morimoto K, Nakayama K (2005) Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 4:27-34
30. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hámáláinen H, Ilanne-Parikka P, Keinánen-Kiukaanniemi S., Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343-1350
31. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe St, Staiger H, Maerker E, Háring H, Stumvoll M (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243
32. Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyörálá K (1998) Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Task Force Report. Eur Heart J 19:1434-1503
33. Yatagai T, Nishida Y, Nagasaka S, Nakamura T, Tokuyama K, Shindo M, Tanaka H, Ishibashi S (2003) Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 50(2):233-238
34. Yokoyama H, Hirose H, Ohgo H, Saito I (2004a) Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 43(6):453-457
35. Yokoyama H, Emoto M, Araki T, Fujiwara S, Motoyama K, Morioka T, Koyama H, Shoji T, Okuno Y, Nishizawa Y (2004b) Effect of aerobic exercise on plasma adiponectin leveles and insulin resistance in type 2 diabetes. Diabetes Care 27(7):1756-1758
36. Zietz H, Herfarth H, Paul G, Ehling A, Müller-Ladner U, Schölmerich J, Scháffler A (2003) Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 545:103-104
37. WHO (1998) Obesity. Preventing and managing the global epidemic. World Health Organization, Geneva